https://h2ecig.com/index.php?route=news/article&news_id=24#intro
Its no secret that Pfizer is losing money on its failed cessation products; such as Chantix & Nicotrol. As it turns out, when your product kills your customers (500 suicides and counting), you lose customers. Q3-2013 earnings were down 15%, amid continuing safety concerns
Also, the Nicotrol Inhaler is losing market share to new generation electronic cigarettes and Pfizer is scrambling to reclaim that lost market. One method has been to publicly scrutinize electronic cigarettes due to safety concerns, which is ironic, considering that their Nicotrol Inhaler is nearly identical in form and function:
Its no secret that Pfizer is losing money on its failed cessation products; such as Chantix & Nicotrol. As it turns out, when your product kills your customers (500 suicides and counting), you lose customers. Q3-2013 earnings were down 15%, amid continuing safety concerns
Also, the Nicotrol Inhaler is losing market share to new generation electronic cigarettes and Pfizer is scrambling to reclaim that lost market. One method has been to publicly scrutinize electronic cigarettes due to safety concerns, which is ironic, considering that their Nicotrol Inhaler is nearly identical in form and function:
